1 Remdesivir and COVID-19
来源:LANCET( P 0140-6736 E 1474-547X ) 发表时间: 2020/10
类型:期刊论文 为本人加分:7216.742854
2 Meta-Analysis on Pharmacogenetics of Platinum-Based Chemotherapy in Non Small Cell Lung Cancer (NSCL..
来源:PLOS ONE( P 1932-6203 E ) 发表时间: 2012/06
类型:期刊论文 为本人加分:4251.295737
3 B.1.617.2 (Delta) Variant of SARS-CoV-2: features, transmission and potential strategies
来源:INT J BIOL SCI( P 1449-2288 E ) 发表时间: 2022/01
类型:期刊论文 为本人加分:3566.417706
贡献度:单独通讯作者
4 eIF3a: A new anticancer drug target in the eIF family
来源:CANCER LETT( P 0304-3835 E 1872-7980 ) 发表时间: 2018/01
类型:期刊论文 为本人加分:3390.238713
5 Pharmacogenomics of platinum-based chemotherapy in non-small cell lung cancer: focusing on DNA repai..
来源:MED ONCOL( P 1357-0560 E 1559-131X ) 发表时间: 2017/04
类型:期刊论文 为本人加分:3251.277846
6 Effect of eIF3a on Response of Lung Cancer Patients to Platinum-Based Chemotherapy by Regulating DNA..
来源:CLIN CANCER RES( P 1078-0432 E 1557-3265 ) 发表时间: 2011/07
类型:期刊论文 为本人加分:3218.488619
7 Prognostic and predictive values of CDK1 and MAD2L1 in lung adenocarcinoma
来源:ONCOTARGET( P E 1949-2553 ) 发表时间: 2016/12
类型:期刊论文 为本人加分:2714.768161
8 The role of CSDE1 in translational reprogramming and human diseases
来源:CELL COMMUN SIGNAL( P E 1478-811X ) 发表时间: 2020/01
类型:期刊论文 为本人加分:2527.248471
贡献度:单独通讯作者
9 mass spectrometry-based personalized drug therapy
来源:MASS SPECTROM REV( P 0277-7037 E 1098-2787 ) 发表时间: 2020/09
类型:期刊论文 为本人加分:2372.196303
贡献度:共同通讯作者
10 Prediction models for platinum-based chemotherapy response and toxicity in advanced NSCLC patients
来源:CANCER LETT( P 0304-3835 E 1872-7980 ) 发表时间: 2016/07
类型:期刊论文 为本人加分:2309.668514